35447272|t|Amyloid beta, Tau, and alpha-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
35447272|a|Aggregation of specific proteins are histopathological hallmarks of several neurodegenerative diseases, such as, Amyloid beta (Abeta) plaques and tau neurofibrillary tangles in Alzheimer's disease (AD); morphologically different inclusions of ratiometric 3 repeat (3 R) and 4 repeat (4 R) tau isoforms in progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and Pick's disease (PiD); alpha-Synuclein (alpha-Syn) containing Lewy bodies (LBs) and dystrophic Lewy neurites (LNs) in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). However, mixed brain protein pathologies have been frequently observed in many of these diseases and in normal aging brains, among which Abeta/tau and tau/alpha-Syn crosstalks have received increased attention. Interestingly, studies have also shown synergistic interplay among Abeta, tau, and alpha-Syn in several neurodegenerative diseases, suggesting a protein triumvirate. In this review, we summarize the emerging evidence of Abeta, tau, and alpha-Syn aggregation in pathophysiology, and their overlap in a spectrum of neurodegenerative diseases including AD, PSP, PiD, CBD, PD and DLB. We discuss the prognostic advancements made in biomarker and imaging techniques in the triumvirate proteinopathies. Finally, we discuss the combined therapeutic modality involving biomarkers and imaging techniques for future combinatorial immunotherapeutic targeting more than one protein aggregates. We hope that such a multitarget therapeutic approach will have synergistic or additive effects to manage neurodegenerative diseases with two or more protein pathologies that might uncover a promising strategy for personalized combination therapies. Managing neurodegenerative diseases by optimizing the diagnostic criteria and the correct combination of immunotherapies will be a key factor in the success of future treatment.
35447272	0	12	Amyloid beta	Gene	351
35447272	14	17	Tau	Gene	4137
35447272	23	38	alpha-Synuclein	Gene	6622
35447272	103	129	neurodegenerative diseases	Disease	MESH:D019636
35447272	207	233	neurodegenerative diseases	Disease	MESH:D019636
35447272	244	256	Amyloid beta	Gene	351
35447272	258	263	Abeta	Gene	351
35447272	277	280	tau	Gene	4137
35447272	308	327	Alzheimer's disease	Disease	MESH:D000544
35447272	329	331	AD	Disease	MESH:D000544
35447272	420	423	tau	Gene	4137
35447272	436	466	progressive supranuclear palsy	Disease	MESH:D013494
35447272	468	471	PSP	Disease	MESH:D013494
35447272	474	499	corticobasal degeneration	Disease	MESH:D000088282
35447272	501	504	CBD	Disease	MESH:D000088282
35447272	511	525	Pick's disease	Disease	MESH:D020774
35447272	527	530	PiD	Disease	MESH:D020774
35447272	533	548	alpha-Synuclein	Gene	6622
35447272	550	559	alpha-Syn	Gene	6622
35447272	572	583	Lewy bodies	Disease	MESH:D020961
35447272	585	588	LBs	Disease	MESH:D020961
35447272	594	618	dystrophic Lewy neurites	Disease	MESH:D058225
35447272	620	623	LNs	Disease	MESH:D058225
35447272	628	647	Parkinson's disease	Disease	MESH:D010300
35447272	649	651	PD	Disease	MESH:D010300
35447272	657	682	dementia with Lewy bodies	Disease	MESH:D020961
35447272	684	687	DLB	Disease	MESH:D020961
35447272	827	832	Abeta	Gene	351
35447272	833	836	tau	Gene	4137
35447272	841	844	tau	Gene	4137
35447272	845	854	alpha-Syn	Gene	6622
35447272	968	973	Abeta	Gene	351
35447272	975	978	tau	Gene	4137
35447272	984	993	alpha-Syn	Gene	6622
35447272	1005	1031	neurodegenerative diseases	Disease	MESH:D019636
35447272	1121	1126	Abeta	Gene	351
35447272	1128	1131	tau	Gene	4137
35447272	1137	1146	alpha-Syn	Gene	6622
35447272	1214	1240	neurodegenerative diseases	Disease	MESH:D019636
35447272	1251	1253	AD	Disease	MESH:D000544
35447272	1255	1258	PSP	Disease	MESH:D013494
35447272	1260	1263	PiD	Disease	MESH:D020774
35447272	1265	1268	CBD	Disease	MESH:D000088282
35447272	1270	1272	PD	Disease	MESH:D010300
35447272	1277	1280	DLB	Disease	MESH:D020961
35447272	1369	1396	triumvirate proteinopathies	Disease	MESH:D057165
35447272	1688	1714	neurodegenerative diseases	Disease	MESH:D019636
35447272	1841	1867	neurodegenerative diseases	Disease	MESH:D019636
35447272	Association	MESH:D020961	4137
35447272	Association	MESH:D020774	4137
35447272	Association	MESH:D013494	351
35447272	Association	MESH:D000544	6622
35447272	Association	MESH:D013494	6622
35447272	Association	MESH:D010300	4137
35447272	Association	MESH:D020961	6622
35447272	Association	MESH:D000544	4137
35447272	Association	4137	6622
35447272	Association	MESH:D020774	6622
35447272	Association	MESH:D019636	6622
35447272	Association	MESH:D010300	351
35447272	Association	MESH:D000544	351
35447272	Association	MESH:D020961	351
35447272	Association	MESH:D000088282	351
35447272	Association	MESH:D020774	351
35447272	Association	MESH:D010300	6622
35447272	Association	MESH:D019636	4137
35447272	Association	MESH:D019636	351
35447272	Association	MESH:D000088282	6622
35447272	Association	MESH:D013494	4137
35447272	Association	MESH:D058225	6622
35447272	Association	MESH:D000088282	4137

